Sort
40,608 grants matching “prostate cancer”
Interference with Androgen Receptor and Its Ligands
$494,453James L Mohler · Univ Of North Carolina Chapel Hill · P01 · FY2012 · CA
Nipple Fluid Hormone Levels and Breast Cancer Risk
$494,452Seema Ahsan Khan · Northwestern University At Chicago · R01 · FY2008 · CA
Fine mapping and characterization of the 8q24 prostate cancer risk locus
$494,436Matthew L Freedman · Dana-Farber Cancer Inst · R01 · FY2008 · CA
Medicare Annual Wellness Visit Practice Redesign Toolkit: A Tailored Intervention to Improve Preventive Health Service Use
$494,272Derjung M Tarn · University Of California Los Angeles · R33 · FY2023 · AG
NSAIDS and Other Medications in Prostate Cancer Etiology
$494,270Fred Hutchinson Cancer Research Center · R01 · FY2001 · CA
MCG Minority-Based Community Clinical Oncology Program
$494,205Anand P Jillella · Augusta University · U10 · FY2011 · CA
NGF recruits nerve fibers to reprogram an immunosuppressive microenvironment in melanoma
$494,201Xiao-Fan Wang · Duke University · R01 · FY2022 · CA
Hybrid Plasma Markers that Complement CT Imaging for Early Lung Cancer Detection
$494,170Paul D Lampe · Fred Hutchinson Cancer Research Center · U01 · FY2016 · CA
Whole Genome Sequencing to Discover Familial Myeloma Risk Genes
$494,158Steven Monroe Lipkin · Weill Medical Coll Of Cornell Univ · R01 · FY2016 · CA
Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer
$494,138Shivendra Singh · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · CA
Molecular Epidemiology of Prostate Cancer in Tobagonians
$494,112Clareann H. Bunker · University Of Pittsburgh At Pittsburgh · R01 · FY2006 · CA
A New Rapid DNA Platform for Neonatal Sepsis Diagnostics
$494,099Dalibor Hodko · Nexogen, Inc. · R44 · FY2018 · HD
World Trade Center Tissue Biobank
$494,044Emanuela Taioli · Icahn School Of Medicine At Mount Sinai · U01 · FY2020 · OH
Pragmatic randomized trial of polygenic risk scoring for common diseases in primary care
$494,035Jason L Vassy · Boston Va Research Institute, Inc. · R35 · FY2023 · HG
World Trade Center Tissue Biobank
$494,014Emanuela Taioli · Icahn School Of Medicine At Mount Sinai · U01 · FY2018 · OH
West Virginia CoHORTS Center
$493,954S. Suresh Madhavan · West Virginia University · R24 · FY2011 · HS
DEVELOPMENT OF A NEW CLASS OF DRUGS TO INHIBIT ALL FORMS OF ANDROGEN RECEPTOR IN CASTRATION-RESISTANT PROSTATE CANCERS
$493,877Hauptman Woodward Medical Research Institute, Inc · · FY2014 · Department of Defense
A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer
$493,712Kristine L Kwekkeboom · University Of Wisconsin-Madison · R01 · FY2013 · NR
Inhibitors of protein-protein interactions
$493,663Nadya Tarasova · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Stromal Foxf2 suppresses prostate cancer progression
$493,644Li Xin · University Of Washington · R01 · FY2022 · CA
BRCA1 TESTING IN A LARGE AFRICAN AMERICAN KINDRED
$493,540University Of Utah · R01 · FY2000 · HG
Breast &Prostate Cancer &Hormone-related Gene Variants
$493,520American Cancer Society, Inc. · U01 · FY2005 · CA
Clinical Trials Involving Vaccine and Standard of Care Cancer Therapies
$493,501Philip M Arlen · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
USP22 Function in Advanced Prostate Cancer
$493,498Karen E Knudsen · Thomas Jefferson University · R01 · FY2017 · CA
USP22 Function in Advanced Prostate Cancer
$493,498Karen E Knudsen · Thomas Jefferson University · R01 · FY2018 · CA